News
Cedars-Sinai Cancer’s Blood and Marrow Transplant Patients Experience Superior Outcomes
Dana-Farber Researchers Explore AI's Potential Roles in Predicting and Diagnosing Cancer
Dana-Farber Cancer Institute Launches Neuro-Inclusive Oncology Care and Empowerment Program
Gordon J. Freeman, PhD, Recognized with 2024 AACR-Cancer Research Institute Lloyd J. Old Award in Cancer Immunology
Bispecific Antibody Therapies for Lymphoma
Pediatric Cancer Expert Explains New Options for Children With Sarcomas
Mapping a Path to Clinical Trials: Bringing Fox Chase’s Innovative Care to the Temple Community
Dana-Farber and Gustave Roussy to Hold Third Transatlantic Exchange: Annual Scientific Conference Dedicated to Advancing Oncology Research and Practice
BCL2 Inhibitors: What’s the Latest Research?
Dana-Farber Cancer Institute Researchers Join Global Cancer Grand Challenges Team Taking on Solid Tumors in Children
Physician Survey Shows Lack of Understanding of the FDA’s Approval Process
Fox Chase Fellows – Winter 2024
Many Legacies to Carry On
Laurie H. Glimcher, MD, Selected for STAT's 2024 STATUS List
Dana-Farber Researchers Receive AACR 2024 Scientific Achievement Awards
Dana-Farber CEO Laurie Glimcher Has Always Been a Trail-Blazer and a Risk-Taker
Antibody-Drug Conjugates: A Cancer Therapy Revolution
Preserving Laryngeal Structure and Function for Patients with Cancer
How to Improve Survival for Pediatric Leukemia Patients
Radioligand Therapy Plus Pembrolizumab May Benefit Patients with Advanced Prostate Cancer
Showing 1 - 20 of 964 results
Previous| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ...49 |Next
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account